{"name":"Joincare Pharmaceutical Group Industry Co., Ltd","slug":"joincare-pharmaceutical-group-industry-co-ltd","ticker":"","exchange":"","domain":"joincareindustry.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"JKN2301 Dry Suspension","genericName":"JKN2301 Dry Suspension","slug":"jkn2301-dry-suspension","indication":"Other","status":"phase_3"},{"name":"JKN2403 Tablets","genericName":"JKN2403 Tablets","slug":"jkn2403-tablets","indication":"Other","status":"phase_2"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"JKN2401 Injection","genericName":"JKN2401 Injection","slug":"jkn2401-injection","indication":"Type 2 diabetes mellitus","status":"phase_3"}]}],"pipeline":[{"name":"JKN2301 Dry Suspension","genericName":"JKN2301 Dry Suspension","slug":"jkn2301-dry-suspension","phase":"phase_3","mechanism":"JKN2301 is an investigational dry suspension formulation designed to improve bioavailability and patient compliance for an undisclosed active pharmaceutical ingredient.","indications":[],"catalyst":""},{"name":"JKN2401 Injection","genericName":"JKN2401 Injection","slug":"jkn2401-injection","phase":"phase_3","mechanism":"JKN2401 is a long-acting GLP-1 receptor agonist that enhances insulin secretion and reduces glucagon levels to improve glycemic control.","indications":["Type 2 diabetes mellitus"],"catalyst":""},{"name":"JKN2403 Tablets","genericName":"JKN2403 Tablets","slug":"jkn2403-tablets","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxPeU5xM05TZjI2Zl93cUNsTXB0Z1BzSUpjVlZxOUFodktpc05sNnZiT3VwWU12X2RqanlKUHV2R0lDVGZJLXFoaTQteUc1LWVsZm05QXFhaG9xV1gxa01pRkI1SVBMM0pBVHNyYThpQVpJZVZSdlFoMXdYRFFwODVrbWN6aTZOWDNJR0xuR3JXdUhjeWF4TWx0Qk5qNEIzVWNoN1hnUFBadldPMzRPODI2UkVCbW43OEh0ZXZwc0R6TVlOQnRs?oc=5","date":"2026-03-31","type":"pipeline","source":"Markets Mojo","summary":"Joincare Pharmaceutical Hits Day Low at CNY 10.96 Amid Price Pressure - Markets Mojo","headline":"Joincare Pharmaceutical Hits Day Low at CNY 10.96 Amid Price Pressure","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxNdFBLX2hOeEdhVHdKNVMtWGNOSWVuTDNOS3BURDVjMGxFUmJpWjlVeHNWRURBNW0wWkZjZkcyd0IxemU5VnlGVm1Nd0hZMVBmb05OVG9IRjl6YmhlZDhRTjIzdnI0R2hLRTllMlFoS25tTDNjNDgzY212SHdkMmN1T3FfTDBjWkFUZmx4ZkQ5RkEtOVJ0SEFzSS1JSUotdVhfUlRXN1BLQkt5Q1ZsckxEdWxwblZLOUlwc1B6UmNfZ1BrSkJY?oc=5","date":"2026-03-31","type":"pipeline","source":"Markets Mojo","summary":"Joincare Pharmaceutical Hits Day Low of CNY 10.30 Amid Price Pressure - Markets Mojo","headline":"Joincare Pharmaceutical Hits Day Low of CNY 10.30 Amid Price Pressure","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVEFVX3lxTFB2MTVVdldKOXEwclFITEpKT3BGLXhGa1QwRFFzOFpDS0k0a2R2VExPYjNYNE1odnNNbk1CWnc1aUlYUnBZSXR4cXdUdVZnLU00QkFWbw?oc=5","date":"2026-03-10","type":"pipeline","source":"Forbes","summary":"Zhu Baoguo & family - Forbes","headline":"Zhu Baoguo & family","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxPY0pZZ3pKc0Y4Qy10RkoySWJMV0xWRGxDZnR4X28ySFU2WHFNNWhndFg0c2pmT0VGUDFBYUJOaFBUbXdmd1VwblYxem9LazBucEc0cVVaQTFRbHhiaHd2eldBNjJyRl91Y0dJUWZvQVlPOFV1VFR0bkt0Zzk2NUtJRmNaUUdsTHFQbElZWGdqY0RzMlFsbERBakdHVWNqdUtXOW5mcGd5VHBLT0liWko5MjY4TTlvcmZEMDZMSVZLVjNqYU5PaE9oM3M3UW42N0xJbkdocVpoX1U3ZWRtODl4VlBHRQ?oc=5","date":"2025-07-04","type":"pipeline","source":"BioSpectrum Asia","summary":"China's Brii Biosciences announces new agreement to address global antimicrobial resistance threats - BioSpectrum Asia","headline":"China's Brii Biosciences announces new agreement to address global antimicrobial resistance threats","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9AFBVV95cUxQVzF6QldwTWYwSzFHRkVRU0pmd3dndmgteU5VemdJdjIyZWlheVRXN0F6VVdVWWRrc2xMSjBoelRRVVhQSmJET05raFpQRHkyenRXYWRTdGg3RUx5dGJWaG9tdHZIYWFicnRyeEM4SkFQZ3BGOVNmS1N2b29ZVldQUVdwWGltWnNVUjN5dkpCZDd6YkZqc3BUdnJWOGNLdzhaeFFqTWptb2RrWlN5U1I4eEJaNE8xRUdPTDFqT25Ja2V0ckl4TnFnV2ltNFdYc3h0OUdJdzdFNk1TU0lSWXlyWWhSMGdMN0x3MkhuRUFDLTFCb3pp?oc=5","date":"2025-07-03","type":"pipeline","source":"PR Newswire","summary":"Brii Biosciences Announces Licensing Agreement with Joincare Group for Rights to BRII-693 in Greater China - PR Newswire","headline":"Brii Biosciences Announces Licensing Agreement with Joincare Group for Rights to BRII-693 in Greater China","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxPTEEzWTdwZG9TcW9oNzMzQVRveUJIUWI3UHFfQ3FBeWczbFN0eTNoLWM0Z3hTeVItWUFxN2NRNFNzaldKMmJvMXNjYUFvMld5T1hLdDNsYjVwTmVkaENIeHdXTlVfdjV5eVlkdjZqRVhxXzd6elBXaTZhTlVVR05ENGE5enRvYU5pcGFoUFZDTDlrNThyazJ2S1dmeTVuc2lvT3R4N2hjeW12WVEyaERoRTdWY0Q2Vl8tNVpoY0tUazZURnZ3akwxNA?oc=5","date":"2025-01-21","type":"pipeline","source":"Citeline News & Insights","summary":"The World’s Top 100 Pharma Companies: 2024 Sales Rankings - Citeline News & Insights","headline":"The World’s Top 100 Pharma Companies: 2024 Sales Rankings - Citeline News & Insights","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxOVXVJdGJvcnZLVXRjX3hsaVlYV1dfbDV3RndnM3AxWUtZRTNKR2NEb3dwY1V5V3lILXc4enVsNmdVenFCYUZpS3BLSF9Sb05nb3JVSElLQ3g4anBvWDJuQnFVM2lEY2Q1U2ZtNEs3QU52bENFWU42ZGJMSHMzcVN4RUd2Nm1pc29wNUZ0WlVNdC1hUVhPQkExYnkwVmY5aEtIVzhfNkNYTQ?oc=5","date":"2024-10-23","type":"pipeline","source":"sz.gov.cn","summary":"Biopharmaceutical industry - sz.gov.cn","headline":"Biopharmaceutical industry","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxQOFhtWGhFeHhuTEpEQUZyUUtKU0ppRGtvWXhTUUphUWgycXhzZVBZMHlvOWFsR3hTODBBd1NqNWtuZVJrS1F5WVJYNG5GMVJ1Z3VlQktlXzR0dDUxUnNLR042VFlpME5kd0l3NC1NWFBjUk5WLUljZGFteXhpUFl1ZVk4RlV6T2w0ZmZJZ1ZUbkU1TGVROEhaMXhCb2RPVmY0NzNDR1ZnNzZPekpWcVE?oc=5","date":"2024-01-10","type":"pipeline","source":"BioWorld News","summary":"Fermion’s FZ-008-145 for pain relief cleared to enter clinic in China - BioWorld News","headline":"Fermion’s FZ-008-145 for pain relief cleared to enter clinic in China","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiV0FVX3lxTFBpVDRNUnVNT1NWZEZMb1pXRVFuX0RqVHFfeXVyaFk0TGFrcXF1X0luZXJONHo3eVNBV2dZdEpGN1drZFJDVzdDd0k3MHJxOXlNYW56eXRnMA?oc=5","date":"2022-10-08","type":"pipeline","source":"TradingView","summary":"F9L Stock Price and Chart — FWB:F9L - TradingView","headline":"F9L Stock Price and Chart — FWB:F9L","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE5wZWYzUktROW4xNDU3WWczaDdTVEdWdmFpeENVdF9mMzlZa1V3bVJ4ZHVxSnFMblVCNmo1ZnNKYjVkWW5QODBNSTR6c3VlQXBWRnc5UHhIbVdTYXVKOVpuVEJwVGNWcDFLOGc?oc=5","date":"2019-01-05","type":"pipeline","source":"TradingView","summary":"Technical Analysis of Joincare Pharmaceutical Group Industry Co., Ltd. Class A (SSE:600380) - TradingView","headline":"Technical Analysis of Joincare Pharmaceutical Group Industry Co., Ltd. Class A (SSE:600380)","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"phase_3":2,"phase_2":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}